help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, H.
Right arrow Articles by Zirkin, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, H.
Right arrow Articles by Zirkin, B. R.
Endocrinology Vol. 143, No. 5 1637-1642
Copyright © 2002 by The Endocrine Society


REPRODUCTION-DEVELOPMENT

Age-Related Decreases in Leydig Cell Testosterone Production Are Not Restored by Exposure to LH in Vitro

Haolin Chen, Matthew P. Hardy and Barry R. Zirkin

Division of Reproductive Biology (H.C., B.R.Z.), Department of Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 21205; and Population Council (M.P.H.), New York, New York 10021

Address all correspondence and requests for reprints to: Dr. Haolin Chen, Department of Biochemistry and Molecular Biology, Division of Reproductive Biology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 21205. E-mail: . hchen{at}jhsph.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Aging in Brown Norway rats is associated with reduced Leydig cell T production. To address the mechanism by which aging Leydig cells become steroidogenically hypofunctional, Leydig cells from young and old rat testes were isolated and cultured long-term with LH. Leydig cells isolated from young rats that had received LH-suppressive T implants served as positive controls. The ability of young control Leydig cells to produce T at high levels was sustained over a 3-d culture period. T production by cells from young LH-suppressed rats increased over this period, almost to control levels. In contrast, culture of the steroidogenically hypofunctional old Leydig cells with LH failed to increase their T production, suggesting that LH stimulation, by itself, is unable to reverse the steroidogenic deficits of old Leydig cells. Reduced numbers of LH binding sites characterized Leydig cells from old rats and LH-suppressed young rats. However, whereas Leydig cells from young LH-suppressed rats produced cAMP at the high levels of young control cells, the old cells produced far less cAMP, suggesting that old Leydig cells have defects in the LH-cAMP signaling cascade. When stimulated with forskolin, old cells produced the same amount of cAMP as young control and young LH-suppressed cells, suggesting that adenylate cyclase is maintained in the old cells. Taken together, these results suggest that inefficient signal transduction may explain the reduced steroidogenesis that characterizes old Leydig cells.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IN BROWN NORWAY rats, as in men, aging is associated with lower serum T concentrations (1, 2, 3). In the rat, this results from the reduced production of T by Leydig cells rather than from loss of Leydig cells (4). As yet, the mechanism by which Leydig cells become steroidogenically hypofunctional with age is uncertain.

In young rats, experimental suppression of serum LH levels results in decreases in Leydig cell volume and T production (5). Reduced Leydig cell volume and T production also characterize aged Leydig cells (4), suggesting the possibility that age-related changes in LH might be responsible for the reduced steroidogenesis that characterizes old Leydig cells. Indeed, although serum LH concentrations in Brown Norway rats do not decline with age (4, 6), changes in LH pulse interval and amplitude do occur (7), and this could have deleterious effects on Leydig cell steroidogenesis.

In a previous study (8), we hypothesized that if reduced T production resulted from age-related changes in LH, the administration of LH to aged rats should restore T production to the higher levels seen in young rats. Exogenously administered LH failed to increase T production by old Leydig cells (8), suggesting that deficient LH stimulation may not be the underlying cause of age-related declines in Leydig cell steroidogenesis. However, other considerations point to a need for continued testing of the role of LH action. First, the administration of comparable doses of LH to young and old rats will not necessarily result in identical intratesticular LH concentrations. For example, testicular regression occurs in a significant proportion of the testes in rats at age 20 months and older (1, 9, 10), which could influence blood flow within the testes and thus affect the delivery of LH to Leydig cells. Second, an extensive extracellular matrix surrounds old but not young Leydig cells (our unpublished data), and this might prevent LH from access to the old cells.

Herein, our objective was to determine whether the exposure of old Leydig cells to LH in vitro would increase the ability of these cells to produce T at rates equivalent to young cells. To this end, Leydig cells from the testes of young and old rats were isolated and cultured long-term with LH. We hypothesized that if the aged-related reduction of T production resulted from LH deficits and not from deficits of the Leydig cells themselves, it should be possible to restore Leydig cell steroidogenic function with LH. We further hypothesized that if the old cells failed to respond to LH, the relative insensitivity of these cells might be due to changes in LH receptor number and affinity, and/or the ability of the cells to produce 3',5'-cAMP in response to LH.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Male Brown Norway rats at ages 4–6 months (young) and 21–24 months (old) were obtained through the National Institute on Aging, supplied by Harlan Sprague Dawley, Inc. (Indianapolis, IN). Rats were housed in controlled light (14-h light, 10-h dark) and temperature (22 C), and had free access to rat chow and water. To experimentally suppress LH, some young rats were administered T via sc polydimethylsiloxane (SILASTIC brand, Dow Corning Corp., Midland, MI) implants. Details of the fabrication of the implants have been described previously (11). Briefly, rats received implants of 3 cm placed sc into the interscapular region for 7 d. All procedures were in accord with the NIH Guide for the Care and Use of Laboratory Animals, with protocols approved by the Johns Hopkins Animal Care and Use Committee.

Leydig cell purification
Leydig cells were isolated as previously described (12). In brief, the testicular artery was cannulated and perfused with collagenase (1 mg/ml, Type 3; Worthington, Freehold, NJ) in dissociation buffer (M-199 medium with 2.2 g/liter HEPES, 1.0 g/liter BSA, 25 mg/liter trypsin inhibitor, 0.7 g/liter sodium bicarbonate, pH 7.4) to clear blood from the testes. Testes were decapsulated and digested in collagenase (0.25 mg/ml, 34 C) with shaking (90 cycles/min, 15 min). The dissociated cells were then subjected to centrifugal elutriation and Percoll gradient centrifugation purification, as previously described (12). The final purity of the Leydig cells obtained this way, determined by staining the cells for 3ß-hydroxysteroid dehydrogenase activity, consistently was about 95%. Cell viability, assessed by trypan blue exclusion, was over 95%.

Culture of isolated Leydig cells with LH in vitro
Leydig cells were cultured according to the procedure described by Klinefelter and Ewing (13). Briefly, purified Leydig cells were resuspended (106/ml) in M-199 medium (Life Technologies, Inc., Grand Island, NY) supplemented with 2.2 g/liter NaHCO3, 2.4 g/liter HEPES, 0.1% BSA, and 12.5 mg/liter gentamycin sulfate, pH 7.4. One-microliter of cell suspension (1.0 x 106) then was added to a Corning, Inc. (Corning, NY) 24-well culture plate containing 0.2 ml of Cytodex 3 beads (Sigma, St. Louis, MO). Bovine lipoprotein (Sigma) was added to provide a final concentration of 0.5 mg/ml. For cells that were cultured for more than 24 h, LH (USDA-bLH-B-6, USDA Animal Hormone Program, Beltsville, MD) was added to a final concentration of 0.5 ng/ml. To determine the maximal 24 h T production, cells were stimulated with 100 ng/ml LH for the final 24 h of culture. This concentration of LH was selected based on the results of previous studies of Leydig cells isolated from Sprague Dawley rats (13), and from preliminary studies of Brown Norway rats. The final culture volume was adjusted to 2.0 ml with M-199 culture medium, and the cultures were maintained at 34C in 5% CO2:5% O2:90% N2.

Media were changed every 24 h. To this end, the Cytodex 3 beads with Leydig cells attached were allowed to settle to the bottom of the culture wells, and the supernatants were collected and frozen for T assay. The beads, with Leydig cells attached, were then resuspended in fresh culture medium and placed in the reduced-oxygen environment. At the end of culture, Leydig cells attached to the beads were lysed with TES buffer (10 mM Tris, pH 8.0; 1 mM EDTA; 1% SDS; 100 mM KCl) at 50 C for 30 min. DNA was assayed fluorometrically with 4',6-diamidino-2-phenylindole (14).

LH receptor analysis
The human CG (hCG) binding assay was performed as previously described (15). In brief, aliquots of 0.5 x 106 Leydig cells were incubated in 0.5 ml culture medium (DMEM-Ham’s F-12, Sigma, supplemented with 0.1% BSA) containing 40,000 cpm of [125I]hCG (NEN Life Science Products, Boston, MA), using 12 x 75 mm polypropylene test tubes. A displacement curve was formed by the addition of cold hCG (0.1–20 ng) to triplicate assay tubes. The tubes were then incubated at 4 C overnight in a multipurpose rotator (Scientific Industries Inc., Bohemia, NY). The tubes were centrifuged at 250 x g for 10 min at 4 C. The pellet was washed twice with 2 ml of cold culture medium and centrifuged. The final pellet was solubilized with 0.5 ml of 0.5 N NaOH. The tubes were then capped and radioactivity was measured in a {gamma}-counter.

Bound ligand per mole of total hCG was plotted against moles of total hCG to free ligand, and the results were subjected to linear regression analysis. The fitted lines were then used to estimate the dissociation constant (Kd), according to the equation: Kd = (-1/slope)/(liter); and the number of binding sites per cell (B), according to the equation: B = (Bmax) (Avogadro’s number)/(no. of cells per tube), where Bmax= X intercept (16, 17).

cAMP and T production
Purified Leydig cells were resuspended (5 x 105/ml) in M-199 medium supplemented with 2.2 g/liter NaHCO3, 2.4 g/liter HEPES, 0.1% BSA, pH 7.4. The cells (1 x 105/200 µl) were preincubated in 96-well Falcon culture plates (Becton Dickinson and Co., Franklin Lakes, NJ) under 5% CO2:95% air at 34 C for 2 h. The medium was then carefully removed and 50 µl fresh phenol-red-free M-199 medium, containing LH or forskolin (Sigma), was added to the plates. For the time-course study, the cells were incubated with 100 ng/ml LH for 5–20 min. For the zero time point, cells were not incubated with LH, but instead lysed with 50 µl TET buffer (0.05 M Tris; 4 mM EDTA; 2 mg/ml theophylline, pH 7.5) after a 2-h preincubation and then frozen in liquid N2 and stored at -80 C. For the dose-response studies, cells were incubated with 50 µl medium containing LH (0–100ng/ml) or forskolin (1–500 µM, diluted from 0.25 M in dimethylsulfoxide) for 20 min after the 2-h preincuabtion. Media were then removed and 50 µl TET buffer was added immediately to the plate. Preparations were frozen in liquid N2 and kept at -80 C until cAMP and T assay. For some cells, isobutyl-methylxanthine (IBMX, Sigma) was included in the medium to inhibit phosphodiesterase activity. cAMP was assayed with a cAMP [3H] assay system (Amersham Pharmacia Biotech, Piscataway, NJ) according to the manufacturer’s directions. The sensitivity of the assay was 0.05 pmol per assay tube. T was assayed by RIA (T antibody from ICN Biomedicals, Costa Mesa, CA; 3H-T from NEN Life Science Products) in the same medium being assayed for cAMP. The sensitivity, intraassay and interassay coefficients of variation of the RIAs for T were 13 pg/tube, 8.9% and 13.6%, respectively.

Statistical analyses
Data are expressed as the mean ± SEM. One-way ANOVA followed by the Scheffé multiple-range test was used to identify differences between groups. Values were considered significant at P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effects of chronic LH stimulation in vitro on Leydig cell steroidogenesis
Figure 1Go shows the capacity of isolated Leydig cells to produce T in response to LH over the course of a 24 h (1 d) culture period, and in the last 24 h of a 3-d culture period. Leydig cells were isolated from young (YC) and old (OC) rats, and from young rats that had received LH-suppressive T implants for 7 d before the isolation (YT). On d 1, young Leydig cells from untreated rats produced significantly more T than old cells or cells from LH suppressed young rats, and cells from old rats produced more T than cells from the LH suppressed rats. With 3 d of culture, cells from young rats were found to have maintained their ability to produce T at high levels, whereas those from old rats did not increase in their ability to produce T. In contrast, the cells from young LH-suppressed rats, which produced only low levels of T on d 1, had a significantly increased ability to produce T by d 3 of culture.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 1. The capacity of Leydig cells to produce T for 1 or 3 d in vitro. During the 3 d of LH stimulation, young control Leydig cells (YC) maintained their high rate of T production (d 1), whereas old control cells (OC) did not increase beyond their low rate. However, the ability of cells from young LH suppressed animals (YT) to produce T increased from d 1 to d 3. Each bar represents the mean ± SEM of four experiments. Groups with different letters are significantly different at P < 0.05.

 
LH receptors/hCG binding
Figure 2Go compares hCG binding sites (2A) and Kd (2B) in young and old Leydig cells, and in cells from LH-suppressed young rats. The number of binding sites per cell and Kd in young control cells are 2.24 ± 0.90 x 104 and 1.42 ± 0.56 nM, respectively. In comparison to the young control cells, decreases in binding sites and in Kd of 50–70% were seen in old cells and in cells from LH-suppressed young rats.



View larger version (34K):
[in this window]
[in a new window]
 
Figure 2. hCG binding sites per cell (A) and Kd (B) in cells from young (YC) and old (OC) rats, and from LH-suppressed young rats (YT). The number of binding sites per young control cell (2.24 ± 0.90 x 104), and the Kd (1.42 ± 0.56 nM) are shown as 100%. In comparison to the young control cells, decreases in binding sites and in Kd of 50–70% were seen in old cells and in cells from LH-suppressed young rats compared with the young control cells. Each bar represents the mean of three experiments. *, Significant differences from YC at P < 0.05. **, Significant difference from YC and OC at P < 0.05.

 
cAMP and T production
For measurements of cAMP (Fig. 3Go) and T (Fig. 4Go) production, cells isolated from the three groups of rats were incubated with maximally stimulating LH (100 ng/ml) for 0–20 min (Figs. 3AGo and 4AGo), or for 20 min with increasing LH concentrations (Figs. 3BGo and 4BGo). With maximally stimulating LH (100 ng/ml), cAMP concentrations reached a plateau within 15 min in all three cell types (Fig. 3AGo). However, the cells from old rats produced significantly less cAMP than cells from both young control and young LH suppressed animals. Interestingly, the cells from the young control and young LH-suppressed rats produced same, relatively high amounts of cAMP despite the significant reduction in LH receptor numbers in cells from LH-suppressed rats (Fig. 2AGo).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 3. Total cAMP content of Leydig cells from young (YC) and old (OC) rats, and from LH-suppressed young rats (YT). Cells were incubated with maximally stimulating LH (100 ng/ml) for 0–20 min (A) or for 20 min with increasing LH concentrations (B). Data are shown as the mean ± SEM of four experiments. OC values were significantly different from YC and YT values at each time point and LH concentration (P < 0.05), except at 0.

 


View larger version (21K):
[in this window]
[in a new window]
 
Figure 4. T production by cells from young (YC) and old (OC) rats, and from LH-suppressed young rats (YT). Cells were incubated with maximally stimulating LH (100 ng/ml) for 0–20 min (A) or for 20 min with increasing LH concentrations (B). Values represent the mean ± SEM of four experiments. YT values were significantly reduced from both YC and OC values at each time point and LH concentration (P < 0.05); OC values were significantly different from YC values (P < 0.05), except at 0.1 ng/ml LH.

 
As shown in Fig. 4Go, incubation of the Leydig cells with maximally stimulating LH resulted in linear increases in T production in all three groups after an initial 5-min delay (Fig. 4AGo). Young control Leydig cells produced significantly more T than old control cells; young LH-suppressed cells produced even less T than the old cells. Under stimulation by different concentrations of LH, T production reached plateaus in the three cell types at about 1 ng/ml LH (Fig. 4BGo). Leydig cells from young LH-suppressed rats had an EC50 that was lower than control young and old cells, but the differences were not significant.

To determine whether impeded function of adenylate cyclase in old cells was responsible for the reduced cAMP production, we incubated cells with forskolin (20 min), an agent known to increase cAMP production by activating adenylate cyclase in Leydig cells (18). Figure 5Go shows the effects of forskolin on cAMP production. At each forskolin concentration from 0–500 µM, cAMP production was equivalent among the three groups of cells, suggesting that adenylate cyclase is maintained in old Leydig cells.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 5. Total cAMP content of cells from young (YC) and old (OC) rats, and from LH-suppressed young rats (YT). Leydig cells were incubated with forskolin (0–500 µM) for 20 min. Values represent the mean ± SEM of four experiments. No significant differences (P < 0.05) were found among YC, OC, and YT at any forskolin concentration.

 
To elucidate whether changes in cAMP degradation are responsible for the reduced cAMP content in LH-stimulated old cells, cells were incubated with a phosphodiesterase inhibitor, IBMX. Figure 6Go shows cAMP production by cells incubated with LH plus IBMX (Fig. 6AGo), or with forskolin plus IBMX (Fig. 6BGo). In the presence of IBMX, the total cellular cAMP produced by the three types of cells increased somewhat, by 5–30%, whether the cells were stimulated with LH (Fig. 6AGo) or with forskolin (Fig. 6BGo). Upon stimulation with LH, old Leydig cells, whether incubated with IBMX or not, produced less cAMP than young control cells or young cells from LH-suppressed rats. In contrast, the three types of cells produced equivalent amounts of cAMP when they were incubated with forskolin, whether in the presence of absence of IBMX. These results suggest that lower cAMP production by old Leydig cells results from lower rates of production and not from increased rates of degradation.



View larger version (39K):
[in this window]
[in a new window]
 
Figure 6. Total cAMP content of Leydig cells from young (YC) and old (OC) rats, and from LH-suppressed young rats (YT). Cells were incubated with 100 ng/ml LH (A) or 500 µM forskolin (B), with or without IBMX, for 20 min. Values represent the mean ± SEM of five experiments. With LH, there were significant (*) decreases in cAMP production by OC, with or without IBMX. With forskolin (B), there were no differences in cAMP production in YC, OC, or YT, with or without IBMX.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In our previous study (8), the administration of LH in vivo did not result in increases in the ability of Leydig cells from old rats to produce T. Rather, T production remained at the low levels observed in age-matched, untreated controls. However, in vivo LH administration does not guarantee that the Leydig cells of young and old rats would be exposed to equivalent concentrations of LH. For example, entry of LH into the testes of old rats might be blocked, and/or LH within the interstitial compartment of the testes might be diluted. In the present study, this uncertainty was circumvented by isolating Leydig cells and culturing them with LH. Leydig cells from rats that had received LH-suppressive T implants served as positive controls for LH responsivity. The rationale for using such cells is that suppression of LH is known to result in the reversible reduction in the ability of young Leydig cells to produce T; i.e. re-exposure of the suppressed cells to LH restores their ability to produce T at high levels (19).

Young Leydig cells sustained their ability to produce T over a 3-d culture period, and, as expected, cells from the LH-suppressed rats increased their T production over the 3-d period almost to control levels. In contrast, culture of the steroidogenically hypofunctional old Leydig cells with LH failed to increase their T production. These results indicate that, whatever the cause of the reduced steroidogenesis that characterizes old Leydig cells, LH stimulation, by itself, apparently is unable to reverse the deficit(s) within 3 d. Moreover, the results support the contention that LH understimulation is unlikely to be responsible for age-related reductions in steroidogenesis by these cells.

Why, then, do old Leydig cells fail to produce high levels of T when cultured with LH, while cells from young LH-deficient cells respond to LH treatment by producing high T levels? We have shown herein that Leydig cells from both old control rats and from young LH-suppressed rats have reduced numbers of LH binding sites. However, whereas the cells from young LH-suppressed rats produced cAMP at the high levels of young control cells, the old cells produced far less cAMP. These results indicate that old Leydig cells may have defects in the LH-cAMP signaling cascade that reduces their responsiveness to LH stimulation. In turn, the reduced ability of these cells to produce cAMP is likely to result in downstream effects, including reductions in StAR (20) and in the steroidogenic enzymes involved in T production (21).

As indicated above, the number of binding sites on Leydig cells, and the affinity of these sites for LH (hCG), change with age. It seems unlikely, however, that the reduced ability of old Leydig cells to produce cAMP results from a deficiency in LH binding. The number of binding sites and binding affinity both changed to an even greater extent in cells from young, LH-suppressed rats than in old cells, but the ability of the former cells to produce cAMP in response to LH did not change. The fact that these cells maintained their ability to produce cAMP despite reduced LH receptor number is not particularly surprising, given a substantial literature indicating that maximal cAMP production can be achieved by LH or hCG binding to only a small fraction of the LH receptors present in Leydig cells (22, 23).

This leads to the question: What changes in the signal transduction pathway of old Leydig cells might cause reductions in cAMP production? LH receptors are coupled to adenylate cyclase through G proteins (24). Forskolin can activate adenylate cyclase by directly binding to the enzyme, thus by-passing the hormone receptor-G protein signal transduction pathway (25). We show here that, under forskolin stimulation, old cells are able to produce the same amount of cAMP as young control and young LH suppressed cells, suggesting that adenylate cyclase is maintained in old cells. Thus the most likely problem(s) is in the quality of the receptors, in the G proteins, and/or in their coupling.

How might aging result in changes in the membrane of old Leydig cells that would result in ineffecient signal transduction? During normal metabolism, cells produce reactive oxygen species that can damage DNA, protein and lipids (26). There is extensive evidence that free radical damage may contribute to cell aging (27, 28). If there were free radical damage to LH receptors or G proteins, the result might be the reduced ability of LH to stimulate cAMP production. Free radical damage to lipids in the cell membrane might influence membrane fluidity (29, 30), and this also might render the LH-cAMP cascade less efficient (31). Indeed, it has been shown that rat aortic endothelial cell membrane fluidity decreases with aging (32). Perhaps more relevant, reduction in rat corpus luteum cell membrane fluidity induced by oxygen radicals has been shown to disrupt LH-stimulated cAMP production (33). Whether or not such a mechanism is involved in Leydig cell aging is under study in our laboratory.


    Acknowledgments
 
The authors are grateful to Ms. Chantal Sottas for her outstanding technical assistance with the LH receptor assay experiments.


    Footnotes
 
This work was supported by NIH Grant AG-08321 from the National Institute on Aging.

Abbreviations: hCG, Human CG; IBMX, isobutyl-methylxanthine; Kd, dissociation constant.

Received October 29, 2001.

Accepted for publication January 24, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Wang C, Leung A, Sinha-Hikim AP 1993 Reproductive aging in the male Brown-Norway rat: a model for the human. Endocrinology 133:2773–2781[Abstract/Free Full Text]
  2. Gruenewald DA, Naai MA, Hess DL, Matsumoto AM 1994 The Brown Norway rat as a model of male reproductive aging: evidence for both primary and secondary testicular failure. J Gerontol 49:B42–B50
  3. Chen H, Luo L, Zirkin BR 1996 Leydig cell structure and function during aging. In: Payne AH, Hardy MP, Russell LD, eds. The Leydig cell. Vienna, IL: Cache River Press; 222–230
  4. Chen H, Hardy MP, Huhtaniemi I, Zirkin BR 1994 Age-related decreased Leydig cell testosterone production in the Brown Norway rat. J Androl 15:551–557[Abstract/Free Full Text]
  5. Ewing LL, Zirkin BR 1983 Leydig cell structure and steroidogenic function. Recent Prog Horm Res 39:599–635
  6. Chen H, Huhtaniemi I, Zirkin BR 1996 Depletion and repopulation of Leydig cells in the testes of aging Brown Norway rats. Endocrinology 137:3447–3452[Abstract]
  7. Bonavera JJ, Swerdloff RS, Leung A, Luo YH, Baravarian S, Superlano L, Sinha Hikim AP, Wang C 1997 In the Brown-Norway male rat, reproductive aging is associated with decreased LH pulse amplitude and area. J Androl 18:359–365[Abstract/Free Full Text]
  8. Grzywacz FW, Chen H, Allegretti J, Zirkin BR 1998 Does age-associated reduced Leydig cell testosterone production in Brown Norway rats result from under-stimulation by luteinizing hormone? J Androl 19:625–630[Abstract/Free Full Text]
  9. Wright WW, Fiore C, Zirkin BZ 1993 The effect of aging on the seminiferous epithelium of the Brown Norway rat. J Androl 14:110–117[Abstract/Free Full Text]
  10. Chen H, Luo L, Zirkin BR 1998 Testicular aging Leydig cells and spermatogenesis. In: Zirkin BR, ed. Germ cell development, division, disruption and death. New York: Springer-Verlag; 130–139
  11. Stratton LG, Ewing LL, Desjardins C 1973 Efficacy of testosterone-filled polydimethylsiloxane implants to maintain plasma testosterone in rabbits. J Reprod Fertil 35:235–244[Abstract/Free Full Text]
  12. Klinefelter GR, Hall PF, Ewing LL 1987 Effect of luteinizing hormone deprivation in situ on steroidogenesis of Leydig cells in the rat. Biol Reprod 36:769–783[Abstract]
  13. Klinefelter GR, Ewing LL 1989 Maintenance of testosterone production by purified adult rat Leydig cells for 3 days in vitro. In Vitro Cell Dev Biol 25:283–288[Medline]
  14. Brunk CF, Jones KC, James TW 1979 Assay for nanogram quantities of DNA in cellular homogenates. Anal Biochem 92:497–500[CrossRef][Medline]
  15. Shan L-X, Hardy MP 1992 Developmental changes in levels of luteinizing hormone receptor and androgen receptor in rat Leydig cells. Endocrinology 131:1107–1114[Abstract/Free Full Text]
  16. Scatchard G 1949 The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672[CrossRef]
  17. Allison RD 1997 Kinetic assay methods. In: Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, Struhl K, eds. Current protocols in molecular biology, Suppl 40. New York: John Wiley & Sons; A.3H.1–A.3H.10
  18. Lin T 1983 Adenosine 3',5'-monophosphate and testosterone responses of normal and desensitized Leydig cells to forskolin. Life Sci 33:2465–2471[CrossRef][Medline]
  19. Wing TY, Ewing LL, Zegeye B, Zirkin BR 1985 Restoration effects of exogenous luteinizing hormone on testicular steroidogenesis and Leydig cell ultrastructure. Endocrinology 117:1779–1787[Abstract/Free Full Text]
  20. Luo L, Chen H, Zirkin BR 2001 Leydig cell aging: steroidogenic acute regulatory protein (StAR) and cholesterol side-chain cleavage enzyme. J Androl 22:149–156[Abstract]
  21. Luo L, Chen H, Zirkin BR 1996 Are Leydig cell steroidogenic enzymes differentially regulated with aging? J Androl 17:509–515[Abstract/Free Full Text]
  22. Catt KJ, Harwood JP, Aguilera G, Dufau ML 1979 Hormonal regulation of peptide receptors and target cell responses. Nature 280:109–116[CrossRef][Medline]
  23. Browne ES, Bhalla VK 1991 Does gonadotropin receptor complex have an amplifying role in cAMP/testosterone production in Leydig cells? J Androl 12:132–139[Abstract/Free Full Text]
  24. Dufau ML, Baukal AJ, Catt KJ 1980 Hormone-induced guanyl nucleotide binding and activation of adenylate cyclase in the Leydig cell. Proc Natl Acad Sci USA 77:5837–5841[Abstract/Free Full Text]
  25. Seamon KB, Day JW 1986 Forskolin: its biological and chemical properties. In: Greengard P, Robison GA, eds. Advances in cyclic nucleotide and protein phosphorylation research, vol 20. New York: Raven Press; 1–150
  26. Chance B, Sies H, Boveris A 1979 Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527–605[Free Full Text]
  27. Knight JA 2000 The biochemistry of aging. Adv Clin Chem 35:1–62[Medline]
  28. Pacifici RE, Davies KJ 1991 Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology 37:166–180[Medline]
  29. Karbownik M, Garcia JJ, Lewinski A, Reiter RJ 2001 Carcinogen-induced, free radical-mediated reduction in microsomal membrane fluidity: reversal by indole-3-propionic acid. J Bioenerg Biomembr 33:73–78[CrossRef][Medline]
  30. Vlasova II 2000 The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity. Platelets 11:406–414[CrossRef][Medline]
  31. Kolena J, Blazicek P, Horkovics-Kovats S, Ondrias K, Sebokova E 1986 Modulation of rat testicular LH/hCG receptors by membrane lipid fluidity. Mol Cell Endocrinol 44:69–76[CrossRef][Medline]
  32. Hashimoto M, Hossain S, Masumura S 1999 Effect of aging on plasma membrane fluidity of rat aortic endothelial cells. Exp Gerontol 34:687–698[CrossRef][Medline]
  33. Wu X, Yao K, Carlson JC 1993 Plasma membrane changes in the rat corpus luteum induced by oxygen radical generation. Endocrinology 133:491–495[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Mol Cancer ResHome page
S. W. Warrenfeltz, S. A. Lott, T. M. Palmer, J. C. Gray, and D. Puett
Luteinizing Hormone-Induced Up-Regulation of ErbB-2 Is Insufficient Stimulant of Growth and Invasion in Ovarian Cancer Cells
Mol. Cancer Res., November 1, 2008; 6(11): 1775 - 1785.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Chandrashekar, C. R. Dawson, E. R. Martin, J. S. Rocha, A. Bartke, and J. J. Kopchick
Age-Related Alterations in Pituitary and Testicular Functions in Long-Lived Growth Hormone Receptor Gene-Disrupted Mice
Endocrinology, December 1, 2007; 148(12): 6019 - 6025.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Shiraishi and M. Ascoli
Lutropin/Choriogonadotropin Stimulate the Proliferation of Primary Cultures of Rat Leydig Cells through a Pathway that Involves Activation of the Extracellularly Regulated Kinase 1/2 Cascade
Endocrinology, July 1, 2007; 148(7): 3214 - 3225.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Chen, L. Luo, J. Liu, and B. R. Zirkin
Cyclooxygenases in Rat Leydig Cells: Effects of Luteinizing Hormone and Aging
Endocrinology, February 1, 2007; 148(2): 735 - 742.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
V. Roulet, H. Denis, C. Staub, A. Le Tortorec, B. Delaleu, A.P. Satie, J.J. Patard, B. Jegou, and N. Dejucq-Rainsford
Human testis in organotypic culture: application for basic or clinical research
Hum. Reprod., June 1, 2006; 21(6): 1564 - 1575.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
L. Luo, H. Chen, M. A. Trush, M. D. Show, M. D. Anway, and B. R. Zirkin
Aging and the Brown Norway Rat Leydig Cell Antioxidant Defense System
J Androl, March 1, 2006; 27(2): 240 - 247.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
L. Luo, H. Chen, and B. R. Zirkin
Temporal Relationships Among Testosterone Production, Steroidogenic Acute Regulatory Protein (StAR), and P450 Side-Chain Cleavage Enzyme (P450scc) During Leydig Cell Aging
J Androl, January 1, 2005; 26(1): 25 - 31.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. P. Hardy and P. N. Schlegel
Testosterone Production in the Aging Male: Where Does the Slowdown Occur?
Endocrinology, October 1, 2004; 145(10): 4439 - 4440.
[Full Text] [PDF]


Home page
EndocrinologyHome page
H. Chen, J. Liu, L. Luo, and B. R. Zirkin
Dibutyryl Cyclic Adenosine Monophosphate Restores the Ability of Aged Leydig Cells to Produce Testosterone at the High Levels Characteristic of Young Cells
Endocrinology, October 1, 2004; 145(10): 4441 - 4446.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. M. Keenan and J. D. Veldhuis
Divergent gonadotropin-gonadal dose-responsive coupling in healthy young and aging men
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R381 - R389.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. J. Rasoulpour, H. A. Schoenfeld, D. A. Gray, and K. Boekelheide
Expression of a K48R Mutant Ubiquitin Protects Mouse Testis from Cryptorchid Injury and Aging
Am. J. Pathol., December 1, 2003; 163(6): 2595 - 2603.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, H.
Right arrow Articles by Zirkin, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, H.
Right arrow Articles by Zirkin, B. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals